Blockade of growth hormone secretagogue receptor 1A signaling by JMV 2959 attenuates the NMDAR antagonist, phencyclidine-induced impairments in prepulse inhibition

Psychopharmacology
Jörgen A EngelEmil Egecioglu

Abstract

Schizophrenic-spectrum patients commonly display deficits in preattentive information processing as evidenced, for example, by disrupted prepulse inhibition (PPI), a measure of sensorimotor gating. Similar disruptions in PPI can be induced in rodents and primates by the psychotomimetic drug phencyclidine (PCP), a noncompetitive inhibitor of the NMDA receptor. Mounting evidence suggests that the hunger hormone ghrelin and its constitutively active receptor influences neuronal circuits involved in the regulation of mood and cognition. In the present series of experiments, we investigated the effects of ghrelin and the growth hormone secretagogue receptor (GHS-R1A) neutral antagonist, JMV 2959, on acoustic startle responses (ASR), PPI, and PCP-induced alterations in PPI. Intraperitoneal (i.p.) administration of ghrelin (0.033, 0.1, and 0.33 mg/kg) did not alter the ASR or PPI in rats. Conversely, i.p. injection of JMV 2959 (1, 3, and 6 mg/kg), dose dependently decreased the ASR and increased PPI. Pretreatment with JMV 2959 at a dose with no effect on ASR or PPI per se, completely blocked PCP-induced (2 mg/kg) deficits in PPI while pretreatment with the highest dose of ghrelin did not potentiate or alter PPI responses of a sub-thre...Continue Reading

References

Sep 1, 1978·The American Journal of Psychiatry·R M Allen, S J Young
Oct 1, 1991·The American Journal of Psychiatry·D C Javitt, S R Zukin
Jan 1, 1987·Schizophrenia Bulletin·R FreedmanR Franks
Jan 1, 1988·Psychopharmacology·R S MansbachD L Braff
Jan 1, 1993·Schizophrenia Bulletin·D L Braff
Aug 1, 1997·Brain Research. Molecular Brain Research·X M GuanA D Howard
Jun 15, 1999·Psychopharmacology·K E Hutchison, R Swift
May 30, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·E J DuncanJ P Rotrosen
Aug 9, 2003·Molecular Endocrinology·Birgitte HolstThue W Schwartz
Oct 25, 2006·The Journal of Clinical Investigation·Alfonso AbizaidTamas L Horvath
Jan 30, 2007·Regulatory Peptides·Kristina W DavisP Shane Clifford
Sep 7, 2007·Regulatory Peptides·Paul J WellmanAudrea E Elliott
Feb 27, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·N R SwerdlowJ Talledo
Apr 10, 2009·European Journal of Pharmacology·Nicolas SaloméSuzanne L Dickson
Jul 1, 2009·Proceedings of the National Academy of Sciences of the United States of America·Elisabet JerlhagJörgen A Engel
May 19, 2010·Addiction Biology·Emil EgeciogluSuzanne L Dickson
Jun 29, 2010·Addiction Biology·Elisabet JerlhagJörgen A Engel
Oct 11, 2011·Neuroscience Letters·Sarah M Jacoby, Paul J Currie
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Meng-Chang TsaiTiao-Lai Huang
Mar 30, 2013·Peptides·Fatemeh GoshadrouSamad Sajjadi
Jan 17, 2014·Alcoholism, Clinical and Experimental Research·Elisabet JerlhagJörgen A Engel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved